Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06452511
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2024-06-01
Brief Title:
Comparing the Effect of Metformin vs Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS
Sponsor:
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Organization:
Al-Azhar University
Study Overview
Official Title:
Comparing the Effect of Metformin vs Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS A Randomized Controlled Open-Label Pilot Study
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to compare the effects of Metformin versus Pep2dia as adjunct treatments to Letrozole on ovulation induction and pregnancy outcomes in overweight women with polycystic ovary syndrome PCOS The main questions it aims to answer are
Does Metformin improve ovulation rates more effectively than Pep2dia when used alongside Letrozole Does Pep2dia enhance pregnancy outcomes compared to Metformin in this patient population
Participants will
Receive either Metformin or Pep2dia in addition to Letrozole Undergo regular monitoring for ovulation and pregnancy outcomes Researchers will compare the Metformin group to the Pep2dia group to see if there is a significant difference in ovulation and pregnancy rates between the two treatments
Does Metformin improve ovulation rates more effectively than Pep2dia when used alongside Letrozole Does Pep2dia enhance pregnancy outcomes compared to Metformin in this patient population
Participants will
Receive either Metformin or Pep2dia in addition to Letrozole Undergo regular monitoring for ovulation and pregnancy outcomes Researchers will compare the Metformin group to the Pep2dia group to see if there is a significant difference in ovulation and pregnancy rates between the two treatments
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None